Mark John Austin
CIK 1713059 · VP Finance/Prin Fin&Acct Offic · last filed 2024-07-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$247.9K
Companies
2
Total Filings
13
Lifetime Open-Market Net
$22.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CATX | VP Finance/Prin Fin&Acct Offic | 84,030 | $2.95 | $247.9K | $0 | 3 | 2024-07-19 |
| Perspective Therapeutics, Inc. (ISR) Delisted | VP Finance/Prin Fin&Acct Offic | 40,230 | $0.38 | $15.4K | $22.6K | 10 | 2022-08-11 |
Recent Filings · Page 2 of 2
13 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-11-15 | Perspective Therapeutics, Inc. (ISR) Delisted | Buy (P) | +2,452 | $1.0K | EDGAR |
| 2018-06-19 | Perspective Therapeutics, Inc. (ISR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-11-24 | Perspective Therapeutics, Inc. (ISR) Delisted | Buy (P) | +9,265 | $4.5K | EDGAR |
Showing 11–13 of 13
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.